Pancreatic stone protein (PSP) is a novel biomarker that is reported to be increased in pneumonia and acute conditions, and PSP appears to be superior to procalcitonin (PCT) in discriminating among patients with infection, infection with sepsis, and no infection [1]. This evidence concerns the gene REG1A and pneumonia.